clinical trial · NCT07029126
Improving the Perception of Stress and Mutuality in Caregivers (MI-DEAR Study) of Migraine Patients With Depressive Symptoms Treated With Fremanezumab: A Study to Evaluate Whether Fremanezumab Reduces the Impact on Caregivers and Increases Couple Reciprocity
Fondazione Policlinico Universitario Campus Bio-Medico·—·recruiting·n = 300
MigraineFremanezumab
brief summary
To evaluate the reduction of emotional burden (measured by Relative Stress Scale-RSS) of caregivers of migraine patients with Depressive Symptoms after 6 months after the first injection of fremanezumab.
started
Oct 3, 2024
primary completion
Oct 30, 2025
completion
Mar 30, 2026
last updated
Jun 19, 2025
official title
Improving the Perception of Stress and Mutuality in Caregivers (MI-DEAR Study) of Migraine Patients With Depressive Symptoms Treated With Fremanezumab: A Prospective Real-life Observational Study to Evaluate Whether Fremanezumab Reduces the Impact on Caregivers and Increases Couple Reciprocity
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol